Through the Innovation Accelerator, the Cancer Service Line (CSL) and the Penn Center for Cancer Care Innovation (PC3I) at the Abramson Cancer Center (ACC) invite applications for initiatives that aim to create and test innovative solutions to address challenges in productivity, efficiency, clinician wellbeing, or access in cancer care at Penn Medicine. Proposals that seek to innovate beyond the ambulatory and hospital settings into the virtual, community, or home settings are encouraged to apply.
We seek proposals for initiatives which:
- Utilize rapid-cycle and innovation approaches to learn and iterate quickly;
- Will be executed within six months;
- Have the potential to: 1) result in large-scale improvements in cancer care, and 2) scale enterprise-wide, including across Penn Medicine entities and/or across cancer disease teams;
- Directly incorporate feedback from key stakeholders, including patients;
- Apply a health equity lens and include approaches to improve equitable access; and
- Align with Cancer Service Line priorities by proposing to improve any one or several of the following domains: productivity, efficiency, clinician wellbeing, access, and/or cancer care beyond the ambulatory and hospital settings.
Selected initiatives will be announced in early January 2023 and launch by the end of January 2023. The initiative period will be six months.
Faculty and staff from across Penn Medicine are encouraged to apply. Submissions not selected to participate in the CSL-PC3I Access Accelerator will still have access to support and advising from Penn Medicine leaders in cancer care delivery and innovation as appropriate.
- November 1, 2022: RFP Release Date
- November 10, 2022 @ 3:30-4:30pm: RFP Virtual Information Session
- November 30, 2022 @ 11:59pm: Submission Deadline
- December 6, 2022: Finalists Announced
- December 14, 2022 @ 9:00am-3:00pm: Innovation Bootcamp and Pitch for Finalists
- January 2023: Selected Initiatives Announced
- January 2023: Initiative Launch
All submissions must be received by 11:59pm ET on November 30, 2022.
Please direct any questions to Sharon Tejada at PC3I: email@example.com.
For a novel investigation into a common and deadly form of liver cancer, PC3I Innovation Fellow Timothy Brown, MD, recently received an ASCO Conquer Cancer Merit Award.
For her work leading innovative research into racial disparities in breast cancer care, Sara Ginzberg, MD, recently received a Clinical Scholar Award from the San Antonio Breast Cancer Symposium.
Four Penn Center for Cancer Care Innovation (PC3I) Faculty will be presenting the latest advances in blood cancer research and treatment at the 64th American Society of Hematology (ASH) Annual Meeting and Exposition.